Literature DB >> 33520400

Behavioral Activation Contributed to the Total Reduction of Depression Symptoms in the Smartphone-based Cognitive Behavioral Therapy: A Secondary Analysis of a Randomized, Controlled Trial.

Hissei Imai1,2,3,4, Mitsuhiko Yamada1,2,3,4, Masatoshi Inagaki1,2,3,4, Norio Watanabe1,2,3,4, Bun Chino1,2,3,4, Akio Mantani1,2,3,4, Toshiaki A Furukawa1,2,3,4.   

Abstract

Objective: The contribution of components in cognitive behavior therapy (CBT) to the total reduction of depression symptoms has not been well elucidated, and previous studies couldn't exclude the human factors in the therapy. Design: This is a secondary analysis of a randomized, controlled trial comparing automated smartphone CBT without human factors plus antidepressant switch against antidepressant switch alone among patients with antidepressant-resistant depression. The present CBT consisted of self-monitoring, behavioral activation, and cognitive restructuring. We used linear regression to predict the overall pre- to post-symptom improvement based on improvement achieved by sessions teaching each cognitive or behavioral skill. The overall improvement was measured with the Beck Depression Inventory-II and the session-to-session improvement with K6.
Results: Of the 164 participants originally enrolled in the study, 94 participants who completed all K6 evaluation were included in the primary analyses. The results indicated that K6 score reduction in the first half of behavioral activation significantly predicted BDI-II score reduction. The sensitivity analysis including 162 participants did not change the result. K6 score reductions after other CBT sessions did not significantly predict BDI-II score reduction.
Conclusion: The behavioral activation seems to contribute to the total reduction of depressive symptoms even if human factors are excluded by using automated smartphone CBT.
Copyright © 2020. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Cognitive behavioral therapy; component study; depression; information technology; smartphone

Year:  2020        PMID: 33520400      PMCID: PMC7839653     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  22 in total

1.  Cognitive-behavioral treatment for depression: relapse prevention.

Authors:  E T Gortner; J K Gollan; K S Dobson; N S Jacobson
Journal:  J Consult Clin Psychol       Date:  1998-04

2.  Toward a Unified Treatment for Emotional Disorders - Republished Article.

Authors:  David H Barlow; Laura B Allen; Molly L Choate
Journal:  Behav Ther       Date:  2016-11-10

3.  Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression.

Authors:  Takahiro Hiroe; Masayo Kojima; Ikuyo Yamamoto; Suguru Nojima; Yoshihiro Kinoshita; Nobuhiko Hashimoto; Norio Watanabe; Takao Maeda; Toshi A Furukawa
Journal:  Psychiatry Res       Date:  2005-06-30       Impact factor: 3.222

4.  Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.

Authors:  Sona Dimidjian; Steven D Hollon; Keith S Dobson; Karen B Schmaling; Robert J Kohlenberg; Michael E Addis; Robert Gallop; Joseph B McGlinchey; David K Markley; Jackie K Gollan; David C Atkins; David L Dunner; Neil S Jacobson
Journal:  J Consult Clin Psychol       Date:  2006-08

5.  Cross-cultural validation of the Beck Depression Inventory-II in Japan.

Authors:  Masayo Kojima; Toshiaki A Furukawa; Hidekatsu Takahashi; Makoto Kawai; Teruo Nagaya; Shinkan Tokudome
Journal:  Psychiatry Res       Date:  2002-07-31       Impact factor: 3.222

Review 6.  What are the active ingredients in cognitive and behavioral psychotherapy for anxious and depressed children? A meta-analytic review.

Authors:  Glen I Spielmans; Leigh F Pasek; Joseph P McFall
Journal:  Clin Psychol Rev       Date:  2007-02-15

7.  Lessons learned from recruiting socioeconomically disadvantaged smokers into a pilot randomized controlled trial to explore the role of Exercise Assisted Reduction then Stop (EARS) smoking.

Authors:  Tom P Thompson; Colin J Greaves; Richard Ayres; Paul Aveyard; Fiona C Warren; Richard Byng; Rod S Taylor; John L Campbell; Michael Ussher; Susan Michie; Robert West; Adrian H Taylor
Journal:  Trials       Date:  2015-02-12       Impact factor: 2.279

Review 8.  Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis.

Authors:  Jürgen Barth; Thomas Munder; Heike Gerger; Eveline Nüesch; Sven Trelle; Hansjörg Znoj; Peter Jüni; Pim Cuijpers
Journal:  PLoS Med       Date:  2013-05-28       Impact factor: 11.069

Review 9.  Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.

Authors:  Halle R Amick; Gerald Gartlehner; Bradley N Gaynes; Catherine Forneris; Gary N Asher; Laura C Morgan; Emmanuel Coker-Schwimmer; Erin Boland; Linda J Lux; Susan Gaylord; Carla Bann; Christiane Barbara Pierl; Kathleen N Lohr
Journal:  BMJ       Date:  2015-12-08

10.  Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial.

Authors:  Akio Mantani; Tadashi Kato; Toshi A Furukawa; Masaru Horikoshi; Hissei Imai; Takahiro Hiroe; Bun Chino; Tadashi Funayama; Naohiro Yonemoto; Qi Zhou; Nao Kawanishi
Journal:  J Med Internet Res       Date:  2017-11-03       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.